The role of androst-5-ene-3β,17β-diol (androstenediol) in cell proliferation in endometrium of women with polycystic ovary syndrome
Abstract
No abstract availableKeywords
Funding Information
- FONDECYT (1100299, 1130053)
- CONICYT Doctoral Thesis (24121153)
- CONICYT Doctoral National Fellowship (21100275)
This publication has 45 references indexed in Scilit:
- Androstenediol complements estrogenic bioactivity during the menopausal transitionMenopause, 2012
- Polycystic ovary syndrome in Salvador, Brazil: a prevalence study in primary healthcareReproductive Biology and Endocrinology, 2012
- Endometrial histology and predictable clinical factors for endometrial disease in women with polycystic ovary syndromeClinical and Experimental Reproductive Medicine, 2011
- Polycystic ovary syndrome increases the risk of endometrial cancer in women aged less than 50 years: an Australian case–control studyCancer Causes & Control, 2010
- Ki67 in breast cancer: prognostic and predictive potentialThe Lancet Oncology, 2010
- Involvement of Akt, Ras and cell cycle regulators in the potential development of endometrial hyperplasia in women with polycystic ovarian syndromeGynecologic Oncology, 2009
- Characterization of a novel telomerase-immortalized human endometrial stromal cell line, St-T1bReproductive Biology and Endocrinology, 2009
- Dehydroepiandrosterone sulfate and insulin resistance in patients with polycystic ovary syndromeFertility and Sterility, 2009
- Impact of Obesity on the Risk for Polycystic Ovary SyndromeThe Journal of Clinical Endocrinology & Metabolism, 2008
- Regulation of the p27Kip1 tumor suppressor by miR‐221 and miR‐222 promotes cancer cell proliferationThe EMBO Journal, 2007